American Century Companies’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-230,341
Closed -$75M 2990
2024
Q1
$75M Buy
230,341
+57,139
+33% +$14M 0.05% 413
2023
Q4
$33M Buy
173,202
+2,336
+1% +$441K 0.02% 668
2023
Q3
$34M Buy
170,866
+89,094
+109% +$21.1M 0.03% 588
2023
Q2
$23.3M Buy
81,772
+65,727
+410% +$18.3M 0.02% 704
2023
Q1
$3.48M Buy
16,045
+3,525
+28% +$687K ﹤0.01% 1394
2022
Q4
$2.57M Buy
12,520
+5,864
+88% +$1.48M ﹤0.01% 1472
2022
Q3
$1.85M Sell
6,656
-42,222
-86% -$10.7M ﹤0.01% 1473
2022
Q2
$9.34M Buy
+48,878
New +$8.63M 0.01% 928

Other funds holding SWAV

American Century Companies's SWAV Position: Q2 2024 in Review

American Century Companies sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 230,341 shares — an estimated $75M sold.

American Century Companies first reported a position in SWAV in Q2 2022 and held it in 8 quarters. The position peaked at $75M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • American Century Companies reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • American Century Companies sold 230,341 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $75M.
  • American Century Companies first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • American Century Companies's Shockwave Medical, Inc. Common Stock position peaked at $75M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.